Skip to main content
. 2011 Oct;24(4):701–717. doi: 10.1128/CMR.00020-11

Table 5.

Resistance of clinical isolates to antimicrobial agentsd

Antimicrobial agent 1993 study (n = 12)a
2001 study (n = 16)b
CHIMED study, 2003-2004 (n = 18)c
MIC50 MIC90 Disk (μg/ml) % sensitivity MIC50 MIC90
Ciprofloxacin 2 8 2 100 ≤1 4
Clarithromycin ≤0.25 ≤0.25 3 100 ≤2 ≤2
Rifabutin ≤0.03 ≤0.03 NT NT ≤0.2 ≤0.2
Rifampin 0.5 1 1 94 0.2 1
Amikacin 4 8 2 100 10 20
Ethionamide R* R* 5 0 NT NT
Streptomycin NT NT 10 100 10 20
Ethambutol R* R* 5 0 >20 >20
Isoniazid 8 >32 0.2 0 ≥20 ≥20
Clofazimine 2 2 NT NT ≤0.5 ≤0.5
Prothionamide NT NT NT NT 5 20
Cycloserine NT NT NT NT 50 >50
a

Data from reference 9. The method applied was a microtiter array with Middlebrook 7H9 broth plus hemin. MICs are in μg/ml.

b

Data from reference 126. The method applied was a disk elution method on Middlebrook 7H10 agar with hemin.

c

The method applied was an agar dilution method on Middlebrook 7H10 medium with a hemin source. MICs are in μg/ml.

d

R*, tested but not active; NT, not tested.